Literature DB >> 28732191

A cardinal sin when researching neuropsin/KLK8: Thou shalt validate antibodies.

Debomoy K Lahiri1, Arpita Konar2, Mahendra K Thakur2, Bryan Maloney3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28732191      PMCID： PMC5875697          DOI： 10.1016/j.jalz.2016.12.016

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


× No keyword cloud information.
  10 in total

1.  Expression of the kallikrein gene family in normal and Alzheimer's disease brain.

Authors:  C Shimizu-Okabe; G M Yousef; E P Diamandis; S Yoshida; S Shiosaka; M Fahnestock
Journal:  Neuroreport       Date:  2001-08-28       Impact factor: 1.837

2.  Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Authors:  Eleftherios P Diamandis; Andreas Scorilas; Tadaaki Kishi; Kaj Blennow; Liu-Ying Luo; Antoninus Soosaipillai; Alfred W Rademaker; Magnus Sjogren
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

3.  Reproducibility crisis: Blame it on the antibodies.

Authors:  Monya Baker
Journal:  Nature       Date:  2015-05-21       Impact factor: 49.962

4.  A proposal for validation of antibodies.

Authors:  Mathias Uhlen; Anita Bandrowski; Steven Carr; Aled Edwards; Jan Ellenberg; Emma Lundberg; David L Rimm; Henry Rodriguez; Tara Hiltke; Michael Snyder; Tadashi Yamamoto
Journal:  Nat Methods       Date:  2016-09-05       Impact factor: 28.547

5.  Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice.

Authors:  Arne Herring; Yvonne Münster; Tamer Akkaya; Sahar Moghaddam; Katharina Deinsberger; Jakob Meyer; Julia Zahel; Eduardo Sanchez-Mendoza; Yachao Wang; Dirk M Hermann; Thomas Arzberger; Sarah Teuber-Hanselmann; Kathy Keyvani
Journal:  Alzheimers Dement       Date:  2016-06-18       Impact factor: 21.566

Review 6.  Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.

Authors:  Asante R Kamkwalala; Paul A Newhouse
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

7.  Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).

Authors:  H H Slunt; G Thinakaran; C Von Koch; A C Lo; R E Tanzi; S S Sisodia
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

8.  Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11.

Authors:  C Hilbich; U Mönning; C Grund; C L Masters; K Beyreuther
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Neuropsin (Opn5): a novel opsin identified in mammalian neural tissue.

Authors:  Emma E Tarttelin; James Bellingham; Mark W Hankins; Russell G Foster; Robert J Lucas
Journal:  FEBS Lett       Date:  2003-11-20       Impact factor: 4.124

10.  Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.

Authors:  Vassiliki Lila Koumandou; Andreas Scorilas
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.